Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...

Descrición completa

Detalles Bibliográficos

Principais autores:	Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2024-12-01
Series:	Human Vaccines & Immunotherapeutics
Assuntos:	HPV-16/18-AS04 human papillomavirus vaccine safety potential immune-mediated diseases pregnancy outcomes
Acceso en liña:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!